[IGOST guideline for pharmacotherapy of low back pain]

MMW Fortschr Med. 2010 Aug 12;152(31-33):44-6. doi: 10.1007/BF03366894.
[Article in German]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Amines / therapeutic use
  • Aminopyridines / therapeutic use
  • Analgesics / therapeutic use
  • Analgesics, Opioid / therapeutic use
  • Anti-Anxiety Agents / therapeutic use
  • Antidepressive Agents / therapeutic use
  • Cyclohexanecarboxylic Acids / therapeutic use
  • Diagnosis, Differential
  • Gabapentin
  • Humans
  • Low Back Pain / diagnosis
  • Low Back Pain / drug therapy*
  • Low Back Pain / etiology
  • Low Back Pain / physiopathology
  • Low Back Pain / psychology
  • Methocarbamol / therapeutic use
  • Muscle Relaxants, Central / therapeutic use
  • Neuromuscular Agents / therapeutic use
  • Osteoporosis / complications
  • Practice Guidelines as Topic*
  • Tolperisone / therapeutic use
  • gamma-Aminobutyric Acid / therapeutic use

Substances

  • Amines
  • Aminopyridines
  • Analgesics
  • Analgesics, Opioid
  • Anti-Anxiety Agents
  • Antidepressive Agents
  • Cyclohexanecarboxylic Acids
  • Muscle Relaxants, Central
  • Neuromuscular Agents
  • Methocarbamol
  • gamma-Aminobutyric Acid
  • Gabapentin
  • Tolperisone
  • flupirtine